Showing results (91-100 of 549) with videos related to

Sort By:
Pageof 55
Tumori|August 12, 2000
Ovarian ablation for premenopausal early-stage breast cancer: an updateL Celio, E Bajetta, L Toffolatti, et al.
American Journal of Clinical Oncology|October 1, 1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustineE Bajetta, R Buzzoni, S Viviani, et al.
Tumori|February 28, 1986
Fine needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility studyT Livraghi, E Bajetta, L Matricardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trialT J Littlewood, E Bajetta, J W Nortier, et al.
The Analyst|August 26, 1998
Speciation as an analytical aid in trace element research in infant nutritionP Brätter, I N Blasco, V E Negretti de Brätter, et al.
Oncology Reports|May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosisN Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews|April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyE Bajetta, N Zilembo, R Buzzoni, et al.
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
Cancer Clinical Trials|January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancerG Tancini, E Bajetta, S Marchini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) groupE Bajetta, N Zilembo, S Barni, et al.
Pageof 55